Business Context and Reporting Period
Company: Mission Produce, Inc. (Parent) and Calavo Growers, Inc. (Company)
Filing Type: Form 8-K (Current Report)
Date of Report: January 14, 2026
Event: Entry into a Material Definitive Agreement (Agreement and Plan of Merger). Mission Produce, Inc. has agreed to acquire Calavo Growers, Inc. in a two-step merger transaction intended to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code.
Key Financial Metrics and Transaction Terms
Consideration Structure: The transaction involves a mix of stock and cash consideration for Calavo shareholders.
- Exchange Ratio: 0.9790 shares of Mission Produce common stock for each share of Calavo common stock.
- Cash Consideration: $14.85 per share of Calavo common stock.
- Fractional Shares: Paid in cash in lieu of fractional shares.
- Tax Treatment Adjustment: If the stock portion of the total consideration falls below 43% of the total value, a portion of the cash consideration will be converted into additional Mission Produce shares to maintain tax-free status.
Equity Award Treatment:
- Options: Automatically vested and cancelled; holders receive cash equal to the excess of the Merger Consideration Value over the exercise price.
- RSUs and Deferred RSUs: Automatically vested and cancelled; holders receive cash equal to the Merger Consideration Value.
Termination Fees:
- Company Fee: Approximately $12.87 million payable by Calavo to Mission Produce under specific termination scenarios (e.g., change in recommendation, superior proposal).
- Reverse Termination Fee: Approximately $15.02 million payable by Mission Produce to Calavo if the merger fails to close by the Termination Date or is prohibited by governmental authority.
Financial Metrics: The filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for either company. These metrics are referenced as being available in separate 10-K and 10-Q filings.
Material Changes and Conditions
Conditions to Closing: The merger is subject to several material conditions, including:
- Approval by shareholders of both Mission Produce and Calavo Growers.
- Expiration or termination of waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act and other applicable antitrust/foreign investment laws.
- Effectiveness of the Registration Statement on Form S-4.
- Authorization for listing of Mission Produce shares on Nasdaq.
- Accuracy of representations and warranties and performance of covenants.
Termination Date: The agreement must be completed on or before July 14, 2026, subject to extensions of up to two 90-day periods if delays are caused solely by antitrust laws.
Guidance, Outlook, and Risks
Management Commentary: The companies intend to create an advanced marketing and sales platform, accelerate innovation, and enhance efficiency. A joint investor presentation and press release were issued on January 14, 2026.
Governance: Upon closing, one director mutually agreeable to both parties will be appointed to the Mission Produce Board of Directors.
Risks and Contingencies:
- Regulatory Risk: Failure to obtain necessary antitrust or foreign investment approvals.
- Shareholder Approval: Risk that requisite votes are not obtained from either company's shareholders.
- Integration Risk: Potential difficulties in integrating operations, realizing synergies, or retaining key personnel.
- Market Risk: Adverse effects on stock prices and potential litigation related to the transaction.
- Forward-Looking Statements: Actual results may differ materially from projections due to economic conditions, client spending, and competitive factors.
Important Facts for Investor Verification
- Verify the final exchange ratio and cash consideration value, as the stock portion may be adjusted to ensure the transaction qualifies as a tax-free reorganization.
- Monitor the status of antitrust reviews (Hart-Scott-Rodino) and other regulatory approvals, which are critical conditions to closing.
- Review the upcoming Joint Proxy Statement/Prospectus (Form S-4) for detailed financial data, risk factors, and voting instructions.
- Confirm the specific terms regarding the treatment of outstanding equity awards (options and RSUs) for individual holders.
- Track the Termination Date of July 14, 2026, and any potential extensions related to regulatory delays.